News | April 01, 2023
ProBioGen delivers strong 2022 performance
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
States advised to undertake mock drills to ensure operational readiness of Hospital Infrastructure including Oxygen Cylinders, PSA plants, ventilators and human resources
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Essex enriches and complements Emmes’ services
The Congress gathers the whole value chain of the pharmaceutical industry on June, 12-13, 2023 in Switzerland
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
The observations are procedural in nature
This is especially the case if the patients are young, have multiple blocks & have conditions that may make angioplasty to implant drug-eluting stents ineffective
Expands robotics to 20+ specialities
Subscribe To Our Newsletter & Stay Updated
